Peer Reviewed Open Access Journal
Methamphetamine (METH) is a potent psychostimulant that induces oxidative stress and hepatotoxicity following prolonged or high-dose exposure. Vitamin A, a fat-soluble antioxidant, has been reported to exert protective effects against oxidative tissue injury. This study evaluated the effect of high-dose vitamin A on methamphetamine-induced liver toxicity in adult male Wistar rats. Twenty adult male Wistar rats were randomly assigned to four experimental groups (n = 5 per group). Group A served as the control and received standard feed and water only; Group B received methamphetamine (10 mg/kg body weight) administered at 3-hour intervals daily; Group C received high-dose vitamin A (2.5 mg/kg body weight); and Group D received methamphetamine in combination with high-dose vitamin A. All experimental animals had free access to standard feed and water throughout the study. The administration was done orally by gavage for 28 consecutive days. Twenty-four hours after the final administration, the animals were anesthetized and sacrificed. The livers were excised, weighed, and fixed in 10% neutral buffered formalin for histopathological examination using haematoxylin and eosin (H&E) staining. Blood samples were collected for the determination of serum liver enzyme activities, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). Body weight results revealed reduction in body weight of the rats in METH treated group while co-administration with high-dose vitamin A mitigated the weight loss. The organ weight assessment revealed an increase in relative liver weight across the experimental groups compared with the control group. However, the methamphetamine-treated group (Group B) exhibited a significantly higher relative liver weight than the control group (P < 0.005). Histological observation revealed that methamphetamine caused liver damage such as hepatocellular degeneration and inflammatory infiltration. Co-treatment with high-dose vitamin A showed improved liver cytoarchitecture suggesting protective effect. In conclusion, methamphetamine caused hepatotoxicity in Wistar rats of the animal models studied while high-dose vitamin A offered hepatoprotection against methamphetamine-induced liver damage.
Vitamin A, Wistar rat, Hepatoprotective, Toxic dose, Methamphetamine
Akanji MA (1986). A Comparative Biochemical Study of the Interaction of some Trypanocides with Rat Tissue Cellular System. PhD Thesis, University of Ife, Ile Ife, Nigeria.
Ajibade T. O., Adebayo J. O., & Ojo O. A. (2020). Methamphetamine-induced hepatotoxicity: Protective role of antioxidants. Journal of Medical Sciences, 12(3), 221–229.
Ajibola O. O., Adeyemi O. S., & Olaniyi O. A. (2021). Protective role of vitamins in drug-induced oxidative stress: A review of biochemical evidence. Toxicology Reports, 8, 1253–1262.
Ali S. F., Newport G. D., & Slikker W. (2015). Methamphetamine-induced oxidative stress and neurotoxicity. Annals of the New York Academy of Sciences, 1025, 132–144.
Azeez O. I., Oyagbemi A. A., & Omobowale T. O. (2020). Vitamin A and E ameliorate oxidative stress and inflammation in drug-induced liver injury. Journal of Basic and Clinical Physiology and Pharmacology, 31(2), 113–121.
Cadet J. L., Jayanthi S., & Deng X. (2003). Speed kills: Cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB Journal, 17(13), 1775–1788.
Coodley E. L., Coodley M. K., & Nelson J. A. (1970). Clinical significance of serum enzyme tests in liver disease. Archives of Internal Medicine, 126(4), 709–716.
Cotran R. S., Kumar V., & Robbins S. L. (1989). Robbins Pathologic Basis of Disease (4th ed.). Philadelphia: W. B. Saunders.
Cruickshank C. C., & Dyer K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104(7), 1085–1099.
El-Nekeety A. A., Abdel-Aziem S. H., Hassan A. M., Attia S. M., & Abdel-Wahhab M. A. (2011). Antioxidant properties of vitamin A against oxidative stress and hepatotoxicity induced by aflatoxin in rats. Toxicology and Industrial Health, 27(3), 241–248.
Geladariss E., Margaritis A., & Tziomalos K. (2024). Methamphetamine-induced hyperthermia and multi-organ injury: Pathophysiological mechanisms and clinical implications. Frontiers in Pharmacology, 15, 1456789.
Gilbert C. (2013). What is vitamin A and why do we need it? Community Eye Health, 26(84), 65.
Gottardi R., Sorio D., Musile G., Trapani E., Seri C., & Pascali J. P. (2020). Methamphetamine-related fatalities and toxicological findings: A retrospective review. Forensic Science International, 311, 110289.
Jayanthi S., Deng X., Ladenheim B., & Cadet J. L. (2020). Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Frontiers in Neuroscience, 14, 594.
Kumar P., Singh R., & Sharma S. (2020). Methamphetamine-induced hepatocellular alterations: An experimental histopathological study in rats. Experimental and Toxicologic Pathology, 72(6), 403–410.
Lin J. C., Chang Y. Y., & Chao M. W. (2017). Methamphetamine causes liver injury through oxidative stress and mitochondrial dysfunction. Toxicology Letters, 280, 139–146.
Liu Y., Lin D., Wu B., & Zhou W. (2019). A review of the mechanisms of methamphetamine-induced neurotoxicity and neuroprotection. Frontiers in Neuroscience, 13, 1312.
Malamo S. O. (2000). Toxicological implication of ceftriaxone administration in rats. Nigerian Journal of Biochemistry and Molecular Biology, 15(1), 33–38.
Moszczynska A., Fitzmaurice P., Ang L., Kalasinsky K. S., & Kish S. J. (2004). Apoptosis and gliosis in the striatum and cortex of human methamphetamine users. Neurobiology of Disease, 15(3), 407–416.
Moss D. W. & Rosalki S. B. (1996). Enzymes in Human Diseases: Diagnosis and Therapy (2nd ed.). London: Chapman & Hall Medical.
Ngaha E. O. (1982). Further studies on the in vivo and in vitro compound. Biochemical Physiology, 73, 109–113.
Northrop N. A., & Yamamoto B. K. (2015). Methamphetamine effects on blood-brain barrier structure and function. Frontiers in Neuroscience, 9, 69.
Nwaogu L. A., Eze J. C., & Udem S. C. (2022). Hepatoprotective effect of antioxidant vitamins in rats exposed to toxicants. Nigerian Journal of Experimental and Clinical Biosciences, 10(2), 45–52.
Partridge B., Lucke J., & Hall W. (2018). Methamphetamine use and associated harms among young people: A public health perspective. Addiction Research & Theory, 26(3), 183–191.
Saleh N. Y., Abdelghany R. F., & Hussein S. A. (2021). Vitamin A supplementation mitigates drug-induced hepatotoxicity via antioxidant mechanisms. Environmental Toxicology and Pharmacology, 87, 103709.
Schmidt C., Schmidt F. W., Hoin D., & Gelarch U. C. (1965). In: Methods of Enzymatic Analysis. Bergmeyer H. U. (ed). Academic Press, New York, pp. 651–712.
Seki T., Nakatani T., & Kinoshita M. (2021). Methamphetamine-induced hepatotoxicity and the role of oxidative stress: Insights from experimental studies. Toxicity Reports, 8, 1451–1460.
Shang N., Xu M., & Liu Y. (2019). Retinoids and liver health: Antioxidant properties and clinical implications. Nutrients, 11(8), 1960.
Singh A., Sharma R., & Kumar S. (2017). Histopathological effects of methamphetamine on liver of Wistar rats. Toxicology Reports, 4, 345–352.
Volkow N. D., Chang L., Wang G. J., Fowler J. S., Franceschi D., Sedler M., & Logan J. (2001). Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. American Journal of Psychiatry, 158(3), 383–389.
Wang Y., Yang X., & Zhou J. (2020). Hepatic effects of methamphetamine exposure: Oxidative injury and inflammatory responses. Toxicology Mechanisms and Methods, 30(4), 290–298.
Wright P. J., Leathwood P. D., & Plummer D. T. (1974). Enzymes in rat urine alkaline phosphatase. Enzymologia, 42, 317–327.
Yakubu M. T., Bilbis L. S., Lawal M., & Akaji M. A. (2003). Effect of repeated administration of sildenafil citrate on selected enzymes activities of liver and kidney of male albino rats. Nigerian Journal of Pure and Applied Sciences, 18, 1395–1400.
Yamamoto B. K., Moszczynska A., & Gudelsky G. A. (2010). Amphetamine toxicities: Classical and emerging mechanisms. Annals of the New York Academy of Sciences, 1187, 101–121.
Yang X., Wang Y., Li Q., Zhong Y., Chen L., Du Y., & Zeng X. (2021). Methamphetamine-induced neurotoxicity and its molecular mechanisms in the central nervous system. Frontiers in Molecular Neuroscience, 14, 700710.
Zhang X., Zhao Y., & Chen J. (2020). Methamphetamine induces hepatocyte apoptosis through oxidative stress and mitochondrial pathway. Life Sciences, 260, 118476.
